New Delhi [India], March 3 (ANI): The Union Health Ministry on Thursday said that any decision on the mixing and matching of the booster dose of COVID-19 vaccines will be taken based on science.
New Delhi [India], February 21 (ANI): Hyderabad-based pharmaceutical company Biological E on Monday received emergency use authorisation from Drugs Controller General of India (DCGI) for its COVID-19 vaccine Corbevax for the 12 to 18 age group.
New Delhi [India], February 15 (ANI): India's third homegrown COVID-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines, said Dr N K Arora, Chairman, India's COVID-19 Working group of National Technical Advisory Group on immun
New Delhi [India], February 15 (ANI): The Drugs Controller General of India (DCGI)'s Subject Expert Committee (SEC) has recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E's COVID-19 vaccine, Corbevax, for the age group 12 to 18 years subject to
New Delhi [India], February 8 (ANI): Covaxin has been granted approval for emergency use in 13 countries as of January 31, 2022, according to the WHO, said Minister of State (MoS) for Health Bharati Pravin Pawar in Lok Sabha on February 4.
New Delhi [India], February 6 (ANI): The Drugs Controller General of India (DCGI) has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine, informed Union Health Minister Mansukh Mandaviya on Sunday.
New York [US], February 2 (ANI): The pharmaceutical companies, Pfizer and BioNTech, are seeking Emergency Use Authorization for their COVID-19 vaccine for use in children between six months and four years of age.
Washington [US], February 1 (ANI): Moderna's COVID-19 vaccine 'Spikevax' received full approval from the U.S. Food and Drug Administration (FDA), after more than a year of its "emergency use authorization", reported USA TODAY.
Manila [Philippines], January 26 (ANI/PNN): The Philippines Food and Drug Administration (FDA) has approved the world's first generic version of Pfizer's anti-Coronavirus pill Paxlovid, just days after the original was granted Emergency Use Authorisation (EUA) by the US FDA.
Gaithersburg [US], January 10 (ANI): Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), on Monday, announced a regulatory submission to the South African Health Products Re
New Delhi [India], December 29 (ANI): With the Drug Controller General of India (DCGI) approving two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, Dr Arjun Dang, CEO, Dr Dangs Lab, welcomed the announcement and said they feel immensely proud "to have been a p
Gaithersburg/Pune (Maryland/Maharashtra)[US/India], December 29 (ANI): Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), the world's largest vaccin